Comments
Actelion's macitentan meets goal in study
30.04.2012. | ZURICH (Reuters) - Europe's biggest biotech company Actelion said on Monday big drug hope macitentan met its goal in a key late stage trial, giving a much-needed boost to the Swiss biotech company's pipeline....
